Literature DB >> 26944747

Clozapine's Effect on Recidivism Among Offenders with Mental Disorders.

Mansfield Mela1, Gu Depiang2.   

Abstract

Mental disorder is associated with criminal reoffending, especially violent acts of offending. Features of mental disorder, psychosocial stresses, substance use disorder, and personality disorder combine to increase the risk of criminal recidivism. Clozapine, an atypical antipsychotic, is indicated in the treatment of patients with psychotic disorders. This article is the report of a community follow-up study of a matched control of those treated with clozapine (n = 41) and those treated with other antipsychotics (n = 21). Rates of reoffending behavior in the general, nonviolent, violent, and sexual categories were calculated after two years of follow-up. Although not statistically significant, the two-year criminal conviction rates of those treated with other antipsychotics in all offense categories except sexual reoffending were two-fold higher than in those treated with clozapine. The time from release to the first offense and crime-free time in the community were significantly longer in the clozapine group. By prolonging the time it takes from release to first offense, clozapine confers additional crime-reduction advantages.
© 2016 American Academy of Psychiatry and the Law.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26944747

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  2 in total

1.  Pharmacological Treatment in Forensic Psychiatry-A Systematic Review.

Authors:  Katarina Howner; Peter Andiné; Göran Engberg; Emin Hoxha Ekström; Eva Lindström; Mikael Nilsson; Susanna Radovic; Monica Hultcrantz
Journal:  Front Psychiatry       Date:  2020-01-16       Impact factor: 4.157

Review 2.  Pharmacotherapy of Primary Impulsive Aggression in Violent Criminal Offenders.

Authors:  Alan R Felthous; Bridget McCoy; Jose Bou Nassif; Rajat Duggirala; Ellen Kim; Fulvio Carabellese; Matthew S Stanford
Journal:  Front Psychol       Date:  2021-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.